Literature DB >> 2420349

Increased EGF receptors on human squamous carcinoma cell lines.

G P Cowley, J A Smith, B A Gusterson.   

Abstract

Characterisation and quantitation of epidermal growth factor receptors (EGFR) have been carried out on eight human squamous carcinoma cell lines and the results compared with those from simian virus transformed keratinocytes and normal keratinocytes grown under similar conditions. All cells tested possess both high and low affinity receptors with dissociation constants ranging from 2.4 X 10(-10) M to 5.4 X 10(-9) M. When epidermal growth factor (EGF) binds to its receptor it is internalised and degraded and the receptor is down regulated. Malignant cells and virally transformed cells possess 5-50 times more EGF receptors than normal keratinocytes and one cell line LICR-LON-HN-5 possesses up to 1.4 X 10(7) receptors per cell, which is the highest number yet reported for a cell line. These results are discussed in the context of recent data that suggest that the increased expression of EGF receptors in epidermoid malignancies may be an important component of the malignant phenotype in these tumours.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2420349      PMCID: PMC2001344          DOI: 10.1038/bjc.1986.39

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  28 in total

1.  The stimulation of epidermal keratinization by a protein isolated from the submaxillary gland of the mouse.

Authors:  S COHEN; G A ELLIOTT
Journal:  J Invest Dermatol       Date:  1963-01       Impact factor: 8.551

2.  Insulin and epidermal growth factor. Human fibroblast receptors related to deoxyribonucleic acid synthesis and amino acid uptake.

Authors:  M D Hollenberg; P Cuatrecasas
Journal:  J Biol Chem       Date:  1975-05-25       Impact factor: 5.157

Review 3.  Factors involved in the modulation of cell proliferation in vivo and in vitro: the role of fibroblast and epidermal growth factors in the proliferative response of mammalian cells.

Authors:  D Gospodarowicz; G Greenburg; H Bialecki; B R Zetter
Journal:  In Vitro       Date:  1978-01

Review 4.  Epidermal growth factor.

Authors:  G Carpenter; S Cohen
Journal:  Annu Rev Biochem       Date:  1979       Impact factor: 23.643

5.  Specific radiolabeling of a cell surface receptor for epidermal growth factor.

Authors:  M Das; T Miyakawa; C F Fox; R M Pruss; A Aharonov; H R Herschman
Journal:  Proc Natl Acad Sci U S A       Date:  1977-07       Impact factor: 11.205

6.  Hormone receptor topology and dynamics: morphological analysis using ferritin-labeled epidermal growth factor.

Authors:  J A McKanna; H T Haigler; S Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

7.  Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin.

Authors:  T A Libermann; H R Nusbaum; N Razon; R Kris; I Lax; H Soreq; N Whittle; M D Waterfield; A Ullrich; J Schlessinger
Journal:  Nature       Date:  1985 Jan 10-18       Impact factor: 49.962

8.  Differentiation of normal and malignant human squamous epithelium in vivo and in vitro: a morphologic study.

Authors:  J Knight; B A Gusterson; G Cowley; P Monaghan
Journal:  Ultrastruct Pathol       Date:  1984       Impact factor: 1.094

9.  Epidermal growth factor and the multiplication of cultured human epidermal keratinocytes.

Authors:  J G Rheinwald; H Green
Journal:  Nature       Date:  1977-02-03       Impact factor: 49.962

10.  Nerve growth factor receptors on human melanoma cells in culture.

Authors:  R N Fabricant; J E De Larco; G J Todaro
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

View more
  28 in total

1.  Anti-EGF receptor monoclonal antibodies: biological studies and potential clinical applications.

Authors:  J Mendelsohn
Journal:  Trans Am Clin Climatol Assoc       Date:  1989

2.  Quantification of the brassinosteroid insensitive1 receptor in planta.

Authors:  G Wilma van Esse; Adrie H Westphal; Ramya Preethi Surendran; Catherine Albrecht; Boudewijn van Veen; Jan Willem Borst; Sacco C de Vries
Journal:  Plant Physiol       Date:  2011-05-26       Impact factor: 8.340

3.  Design of surfaces for liquid crystal-based bioanalytical assays.

Authors:  Aaron M Lowe; Byram H Ozer; Yiqun Bai; Paul J Bertics; Nicholas L Abbott
Journal:  ACS Appl Mater Interfaces       Date:  2010-03       Impact factor: 9.229

4.  Consumption of EGF by A431 cells: evidence for receptor recycling.

Authors:  H Masui; L Castro; J Mendelsohn
Journal:  J Cell Biol       Date:  1993-01       Impact factor: 10.539

5.  EGFR forms ligand-independent oligomers that are distinct from the active state.

Authors:  Patrick O Byrne; Kalina Hristova; Daniel J Leahy
Journal:  J Biol Chem       Date:  2020-07-29       Impact factor: 5.157

6.  Targeting HER3 with miR-450b-3p suppresses breast cancer cells proliferation.

Authors:  Zhen Zhao; Rui Li; Sha Sha; Qiong Wang; Weidong Mao; Tao Liu
Journal:  Cancer Biol Ther       Date:  2014-07-21       Impact factor: 4.742

7.  Epidermal growth factor receptor expression on oral mucosa dysplastic epithelia and squamous cell carcinomas.

Authors:  M E Christensen; M H Therkildsen; B L Hansen; H Albeck; G N Hansen; P Bretlau
Journal:  Eur Arch Otorhinolaryngol       Date:  1992       Impact factor: 2.503

8.  Epidermal growth factor receptor and lipid membrane components in human lung cancers.

Authors:  A Di Carlo; A Mariano; P E Macchia; C Cecere; G Ferrante; V Macchia
Journal:  J Endocrinol Invest       Date:  1993-02       Impact factor: 4.256

9.  Prognostic significance of epidermal growth factor receptor in squamous cell carcinoma of the maxillary sinus.

Authors:  M Miyaguchi; S Sakai; J Olofsson; H Kuwabara; H Sakamoto
Journal:  Eur Arch Otorhinolaryngol       Date:  1993       Impact factor: 2.503

Review 10.  Cell, tissue and organ culture as in vitro models to study the biology of squamous cell carcinomas of the head and neck.

Authors:  P G Sacks
Journal:  Cancer Metastasis Rev       Date:  1996-03       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.